Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Probst

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cellular and Molecular Neurobiology|October 1, 1994
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in ratsT Skutella, A Montkowski, T Stöhr, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1995
V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in ratsR Landgraf, R Gerstberger, A Montkowski, et al.
European Journal of Pharmacology|December 16, 1998
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in ratsM Engelmann, R Landgraf, P Lörscher, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1994
Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performanceT Skutella, T Stöhr, J C Probst, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 1996
Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptideJ C Probst, T Zetzsche, M Weber, et al.
The European Journal of Neuroscience|February 1, 1997
Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviourT Skutella, R K Schwarting, J P Huston, et al.
Neuroreport|October 27, 1994
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in ratT Skutella, H Criswell, S Moy, et al.
European Journal of Pharmacology|July 23, 1997
Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effectsB Schöbitz, G Pezeshki, J C Probst, et al.
Regulatory Peptides|October 20, 1995
Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated ratsG Liebsch, R Landgraf, R Gerstberger, et al.
Southern Medical Journal|May 8, 2000
Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research TeamR Oldendick, A L Coker, D Wieland, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cellular and Molecular Neurobiology|October 1, 1994
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in ratsT Skutella, A Montkowski, T Stöhr, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1995
V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in ratsR Landgraf, R Gerstberger, A Montkowski, et al.
European Journal of Pharmacology|December 16, 1998
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in ratsM Engelmann, R Landgraf, P Lörscher, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1994
Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performanceT Skutella, T Stöhr, J C Probst, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 1996
Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptideJ C Probst, T Zetzsche, M Weber, et al.
The European Journal of Neuroscience|February 1, 1997
Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviourT Skutella, R K Schwarting, J P Huston, et al.
Neuroreport|October 27, 1994
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in ratT Skutella, H Criswell, S Moy, et al.
European Journal of Pharmacology|July 23, 1997
Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effectsB Schöbitz, G Pezeshki, J C Probst, et al.
Regulatory Peptides|October 20, 1995
Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated ratsG Liebsch, R Landgraf, R Gerstberger, et al.
Southern Medical Journal|May 8, 2000
Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research TeamR Oldendick, A L Coker, D Wieland, et al.
Pageof 5